Sign Up to like & get
recommendations!
0
Published in 2017 at "Electrochemistry Communications"
DOI: 10.1016/j.elecom.2017.10.003
Abstract: Abstract As recently as 2006 the mitochondrial amidoxime reducing component (mARC) was identified as the fourth and last Mo enzyme present in humans. Its physiological role remains unknown. mARC is capable of reducing a variety…
read more here.
Keywords:
mitochondrial amidoxime;
substrates inhibitors;
amidoxime reducing;
reducing component ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Drug Metabolism and Disposition"
DOI: 10.1124/dmd.118.082453
Abstract: The mitochondrial amidoxime reducing component is a recently discovered molybdenum enzyme in mammals which, in concert with the electron transport proteins cytochrome b5 and NADH cytochrome b5 reductase, catalyzes the reduction of N-oxygenated structures. This…
read more here.
Keywords:
mitochondrial amidoxime;
amidoxime reducing;
system;
metabolism ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug Metabolism and Disposition"
DOI: 10.1124/dmd.121.000805
Abstract: Mitochondrial amidoxime-reducing component (mARC) enzymes are molybdenum-containing proteins that metabolize a number of endobiotics and xenobiotics. The interindividual variability and differential tissue abundance of mARC1 and mARC2 were quantified using targeted proteomics in three types…
read more here.
Keywords:
mitochondrial amidoxime;
reducing component;
tissue;
abundance ... See more keywords